XIII PPH plus Expert Workshop – Part II of II – The PPH plus Newsletter

PPH plus completes the summary of the XIII Interdisciplinary Drug Development Expert Workshop (Frankfurt Biotech Innovation Center - FIZ, Frankfurt am Main, 20 April 2018) with the presentations summary and slides concerning Product-Specific Safety Surveillance of Biologicals/ Biosimilars, Points to Consider in Orphan Drug Development, and Risk-based Quality Management (RBQM) in the second part of the May PPH plus Newsletter.

Dr. med. Johanna Schenk, Managing Director & COO, concluded the meeting by extending “A big thank-you to all, today’s expert speakers and multidisciplinary expert attendees, on behalf of the PPH plus team, for the engaging discussions in this 2018 event. In cooperation with the new leadership by SanaClis s.r.o. we will challenge ourselves with the selection of highly topical drug development themes and look forward to welcoming you back on 17 May 2019, the date set for the XIV Expert Workshop”.

2018-05-04_News_Picture_1.jpg2018-05-04_News_Picture_2.jpg
2018-05-04_News_Picture_3.jpg2018-05-04_News_Picture_4.jpg
2018-05-04_News_Picture_5.jpg2018-05-04_News_Picture_6